Whether you are starting Mounjaro (tirzepatide) for the first time or transferring from another provider, two important considerations are whether your prescribed dose is available and what your treatment is likely to cost over time. This page brings together EverydayMeds' full range of Mounjaro strengths, current pricing for each strength, and a clear guide to transferring your treatment from another provider while helping to support continuity of care.
Treatment suitability is always determined following an individual clinical assessment by a qualified UK prescriber. The information on this page is provided for general guidance and does not replace a personalised clinical assessment.
What Is Mounjaro Weight Loss Injections?
Mounjaro is the brand name for tirzepatide, a prescription only weekly injection manufactured by Eli Lilly and Company. It is licensed in the UK for weight management alongside a reduced calorie diet and increased physical activity, and separately for the treatment of type 2 diabetes.
If you are wondering how Mounjaro works, tirzepatide is the active ingredient and acts on two gut hormone pathways, GIP and GLP 1. These pathways are involved in appetite regulation and blood sugar control. Tirzepatide may also slow digestion, which can help support weight management when used alongside lifestyle changes.
Mounjaro is supplied as a pre filled pen and is available in six strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg.
In clinical trials, participants receiving tirzepatide alongside diet and physical activity achieved average weight reductions of up to 22.5% over 72 weeks. Individual results varied, and weight loss outcomes depend on factors such as treatment response, dose, and lifestyle changes.
This page does not recommend which Mounjaro strength is right for you. Your starting dose and any dose changes are decided by your prescriber based on your individual circumstances.
Mounjaro Doses, Pricing Transparency, and Full UK Pricing
Every Mounjaro strength is available to order, subject to clinical assessment and stock availability.
Prices below are shown at the standard rate, first order rate, and ongoing returning customer rate. The live pricing table on this page always takes precedence, as prices may change over time.
Across the wider UK market, Mounjaro prices can vary between providers and may range from around £99 to £359 per month, depending on factors such as the prescribed strength, service included, and provider pricing.
| Strength | Standard price | First order (FIRST40) | Returning customer |
|---|---|---|---|
| 2.5mg | £169.99 | £129.99 | £144.99 |
| 5mg | £199.99 | £159.99 | £174.99 |
| 7.5mg | £249.99 | £209.99 | £224.99 |
| 10mg | £269.99 | £229.99 | £244.99 |
| 12.5mg | £299.99 | £259.99 | £274.99 |
| 15mg | £318.99 | £278.99 | £293.99 |
Starter doses in the market typically range from £100 to £249. Monthly costs for maintenance doses, especially 15mg, generally range from £289 to £359. Delivery fees are often charged separately and usually range from £3 to £5.
Bundle Pricing
| Bundle | Contents | Standard | First order |
|---|---|---|---|
| Intro Duo | 2.5mg + 5mg · 8 weeks | £339.99 | £299.99 |
| Progress Duo | 5mg + 7.5mg · 8 weeks | £409.99 | £369.99 |
| Advance Duo | 7.5mg + 10mg · 8 weeks | — | £449.99 |
| Intro Trio | 2.5mg + 5mg + 7.5mg · 12 weeks | £574.99 | £534.99 |
| Progress Trio | 5mg + 7.5mg + 10mg · 12 weeks | — | £634.99 |
New customers can save £40 with code FIRST40, subject to the current offer terms.
Returning customers receive £25 off, automatically applied at checkout. This is a repeat customer discount available on future orders while the offer remains active.
What £25 Off Every Reorder Actually Saves You
Because Mounjaro treatment may involve multiple reorders over time rather than a single purchase, returning customer discounts can provide ongoing savings when available.
For example, if a patient moves from a 2.5 mg starting dose to a higher maintenance dose over several reorders, repeat order discounts may add up over the course of treatment. When comparing suppliers, it is worth considering the overall cost of ongoing treatment rather than focusing only on the initial order price.
Why All Doses Are Kept In Stock
EverydayMeds provides access to all six Mounjaro strengths, subject to stock availability and clinical approval. Medication is sourced through licensed UK wholesalers and supplied following the appropriate prescribing and dispensing process.
This helps support patients who are prescribed different strengths during their treatment journey. Availability can change, so patients should check the latest stock information before ordering.
EverydayMeds' supply information relates to its own service and does not make comparisons with other suppliers.
How to Switch Your Mounjaro Supplier
Moving to a new supplier does not necessarily mean starting your treatment from the beginning. The process typically involves:
- Completing a short online clinical assessment, including information about your current Mounjaro dose, how long you have been taking it, your medical history, and any current medications.
- Providing details of your current prescription or most recent pen, where required, so the prescriber can review your treatment history. Avoid purchasing Mounjaro from unregulated sources, as medicines from these sellers may carry risks, including counterfeit products.
- A UK registered prescriber reviewing your information and confirming whether your current dose is clinically appropriate. Continuation of the same dose is not automatic and will depend on the prescriber's assessment.
- Once approved, your order is dispensed and dispatched. Express 24 hour assessment may be available for patients who require a faster review, subject to clinical demand.
Stock availability may vary, so it is recommended to complete the ordering process promptly after approval where applicable.
Express Clinical Assessment
Standard clinical assessment takes up to 3 working days. An express option is available for a small additional fee, giving you a decision within 24 hours — useful if you're close to running out of your current supply and want to avoid a gap in treatment.
Am I Eligible for Mounjaro?
Mounjaro in the UK may be available privately or through the NHS, depending on eligibility criteria. Private prescribing decisions are made on an individual basis, while NICE guidance on tirzepatide for weight management recommends considering treatment for adults who meet specific criteria, including:
- A BMI of 35 kg/m² or above.
- A BMI of 27.5 to 34.9 kg/m² for people from South Asian, Chinese, other Asian, Middle Eastern, Black African, or African Caribbean backgrounds, where lower BMI thresholds may apply.
- At least one weight related health condition, such as high blood pressure, high cholesterol, or osteoarthritis.
A BMI of 30 or above is commonly used as a private prescribing eligibility threshold, although final suitability is always determined by a prescriber following a clinical assessment. NHS access criteria may be more specific and depend on local eligibility requirements.
Private treatment may involve additional costs compared with NHS access.
(Source: NICE Technology Appraisal TA1026, "Tirzepatide for managing overweight and obesity," published December 2024.)
Speak to a prescriber before starting treatment if you are:
- Pregnant, trying to conceive, or breastfeeding.
- Living with a history of certain thyroid cancers or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
- Managing pancreatic conditions, including pancreatitis, or certain digestive conditions.
- Under the age of 18.
Trust and Safety
- GPhC registered UK pharmacy. OVIO LTD, trading as EveryDayMeds, sources Mounjaro (tirzepatide) through licensed UK wholesalers. Legitimate online pharmacies dispensing prescription medicines in Great Britain must be registered with the GPhC.
- Buying prescription medicines from unregulated sources, including social media sellers, may increase the risk of receiving counterfeit or unsafe products.
- Independent prescriber review is completed for each prescription request, including when patients transfer from another supplier.
- Mounjaro is subject to additional monitoring by the MHRA through the black triangle scheme. The clinical team follows relevant safety monitoring and reporting requirements.
- Transparent per dose pricing is shown above at standard, first order, and returning customer rates.
Safety Information
Mounjaro is a prescription only medicine and should only be used under the supervision of an appropriately qualified prescriber.
Commonly reported gastrointestinal side effects include nausea, diarrhoea, decreased appetite, vomiting, and constipation. These side effects are more commonly reported during dose escalation and may improve as the body adjusts to treatment. Injection site reactions, such as redness or itching, may also occur.
Your prescriber will discuss the safety profile, potential side effects, and any reasons why Mounjaro may not be suitable for you during your consultation.
Dose adjustments, where appropriate, are decided by your prescriber in line with the licensed dosing schedule. If you miss a dose, follow the instructions in the Patient Information Leaflet or advice provided by your prescriber.
Mounjaro pens should be stored according to the instructions provided in the Patient Information Leaflet.
This page provides general information and does not replace the Patient Information Leaflet supplied with your medication or advice from your healthcare professional.
Clinical review note: Confirm the side effect summary and storage information against the current Mounjaro Summary of Product Characteristics (SmPC) and Patient Information Leaflet (PIL) before publication.
